We also studied the influence of UGT2B17 mRNA expression levels in peripheral mononuclear blood cells (PBMCs) and UGT2B17 common deletion polymorphism on circulating steroid levels of CLL patients, and their relationship to TFS. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.